Jefferies Financial Group upgraded shares of Cardinal Health (NYSE:CAH - Free Report) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning, Marketbeat.com reports. They currently have $150.00 target price on the stock, up from their previous target price of $140.00.
CAH has been the subject of several other reports. Deutsche Bank Aktiengesellschaft lifted their target price on Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a research report on Monday, November 4th. UBS Group upped their target price on Cardinal Health from $134.00 to $139.00 and gave the stock a "buy" rating in a report on Monday, November 4th. TD Cowen upgraded Cardinal Health from a "hold" rating to a "buy" rating and raised their price target for the company from $130.00 to $144.00 in a research note on Wednesday, January 8th. StockNews.com cut shares of Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd. Finally, Mizuho assumed coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They set an "outperform" rating and a $139.00 price objective on the stock. Four research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $136.87.
Check Out Our Latest Stock Analysis on CAH
Cardinal Health Stock Performance
NYSE CAH traded up $0.57 on Wednesday, hitting $127.62. 1,797,495 shares of the stock were exchanged, compared to its average volume of 2,327,426. Cardinal Health has a 52-week low of $93.17 and a 52-week high of $132.84. The firm has a market capitalization of $30.83 billion, a P/E ratio of 23.81, a P/E/G ratio of 1.49 and a beta of 0.63. The stock has a fifty day moving average price of $122.46 and a two-hundred day moving average price of $115.14.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts' consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Sell-side analysts expect that Cardinal Health will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.58%. The ex-dividend date of this dividend is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is presently 37.69%.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. State Street Corp raised its position in Cardinal Health by 4.6% during the 3rd quarter. State Street Corp now owns 14,177,641 shares of the company's stock worth $1,566,913,000 after buying an additional 627,253 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Cardinal Health during the fourth quarter worth $45,115,000. Two Sigma Advisers LP raised its holdings in shares of Cardinal Health by 47.9% during the third quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company's stock valued at $118,197,000 after acquiring an additional 346,362 shares during the last quarter. Caisse DE Depot ET Placement DU Quebec boosted its stake in shares of Cardinal Health by 230.0% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 477,911 shares of the company's stock worth $52,819,000 after acquiring an additional 333,095 shares during the last quarter. Finally, Wedge Capital Management L L P NC acquired a new position in Cardinal Health in the 3rd quarter valued at $30,820,000. Hedge funds and other institutional investors own 87.17% of the company's stock.
Cardinal Health Company Profile
(
Get Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
